Venture firm a16z raises $700M; Ribo Life’s $230M Hong Kong IPOnews2026-01-09T16:26:48+00:00January 9th, 2026|Endpoints News|
MoonLake revives FDA push; Biotech trio to debut in Hong Kongnews2026-01-08T16:15:06+00:00January 8th, 2026|Endpoints News|
BridgeBio shares KRAS data; Hutchmed’s Phase 3 success in Chinanews2026-01-07T15:26:03+00:00January 7th, 2026|Endpoints News|
Roche’s patent deal with Structure; AstraZeneca reports lupus datanews2026-01-06T14:49:42+00:00January 6th, 2026|Endpoints News|
Moderna seeks flu vaccine approvals; Neumora Alzheimer’s datanews2026-01-05T16:08:37+00:00January 5th, 2026|Endpoints News|
ASK Pharm makes China rights deal; Unicycive resubmits kidney drug after CRLnews2025-12-29T17:42:33+00:00December 29th, 2025|Endpoints News|
Gilead’s herpes deal; FDA approvals for Boehringer, Rochenews2025-12-23T14:46:06+00:00December 23rd, 2025|Endpoints News|
Altimmune advances in MASH; New China obesity biotech; Ipsen Phase 2 failnews2025-12-19T15:41:31+00:00December 19th, 2025|Endpoints News|
Subcutaneous Rybrevant; Kalaris shares nAMD data; Pyxis disappointsnews2025-12-18T15:47:22+00:00December 18th, 2025|Endpoints News|
Vir licensing deal; Cytokinetics wins China nod; Vistagen’s social anxiety failnews2025-12-17T15:00:12+00:00December 17th, 2025|Endpoints News|
